机构地区:[1]Department of Interventional Radiology,The University of Texas MD Anderson Cancer Center,Houston 77030,USA [2]Baylor College of Medicine,Houston 77030,USA [3]College of Medicine,University of the Philippines Manila,1000 Manila,Philippines [4]Department of Nanomedicine,Houston Methodist Research Institute,Houston 77030,USA [5]Department of Chemistry,Lamar University,Beaumont 77710,USA [6]Department of Veterinary Medicine and Surgery,The University of Texas MD Anderson Cancer Center,Houston 77030,USA [7]Department of Imaging Physics,The University of Texas MD Anderson Cancer Center,Houston 77030,USA [8]Section of Nephrology,Department of Medicine,Selzman Institute for Kidney Health,Baylor College of Medicine,Houston 77030,USA [9]The University of Texas MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences,Houston 77030,USA
出 处:《Advanced Fiber Materials》2023年第6期1986-2001,共16页先进纤维材料(英文)
基 金:the National Institutes of Health—National Heart,Lung,and Blood Institute(5HL141831-05 and 1R01HL159960-01A1);a Radiological Society of North America Research Seed Grant(RSD2012);a Society of Interventional Radiology Pilot Research Grant,an MD Anderson Center for Advanced Biomedical Imaging Pilot Project Program Research Grant;the National Institutes of Health—National Cancer Institute through MD Anderson's Cancer Center Support Grant(P30CA016672,used the Research Animal Support Facility and Small Animal Imaging Facility).
摘 要:Arteriovenous fistulas(AVFs)are a vital form of AV access for patients requiring hemodialysis,but they link to overall morbidity and mortality when they fail to mature.The most common cause of AVF non-maturation is neointimal hyperplasia(NIH).To minimize the deleterious effects of NIH,a perivascular wrap composed of polycaprolactone(PCL),rosuvastatin(ROSU),and gold nanoparticles(AUNPs)was constructed.This study assessed the impact of ROSU-eluting,radiopaque resorbable perivascular wraps on pathologic NIH in a chronic kidney disease(CKD)rodent model of AVF.Electrospun PCL wraps containing AuNPs and/or ROSU were monitored for in vitro tensile strength,AuNP release,ROSU elution,and effect on cellular viability.The wraps were then implanted around an AVF in a CKD rodent model for in vivo ultrasound(US)and micro-computed tomography(mCT)imaging.AVF specimens were collected for histological analyses.Cell viability was preserved in the presence of both AuNP-and ROSU-containing wraps.In vitro release of ROSU and AuNPs correlated with in vivo findings of decreasing radiopacity on mCT over time.AuNP-loaded wraps had higher radiopacity(1270.0-1412.0 HU at week 2)compared with other wraps(103.5-456.0 HU),which decreased over time.The addition of ROSU decreased US and histologic measurements of NIH.The reduced NIH seen with ROSU-loaded perivascular wraps suggests a synergistic effect between mechanical support and anti-hyperplasia medication.Furthermore,AuNP loading increased wrap radiopacity.Together,our results show that AuNP-and ROSU-loaded PCL wraps induce AVF maturation and suppress NIH while facilitating optimal implanted device visualization.
关 键 词:Arteriovenous fistula Chronic kidney disease Nanoparticles POLYCAPROLACTONE RADIOPACITY ROSUVASTATIN
分 类 号:TB383[一般工业技术—材料科学与工程]
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...